United States · FDA National Drug Code directory

Naproxen Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
21130-948_23615188-2795-b75b-e063-6394a90a9728
Product NDC
21130-948
Form
CAPSULE, LIQUID FILLED
Composition / generic term
Naproxen Sodium
Labeler
Albertsons Companies
Marketing category
NDA
Marketing start / end (source format)
20230926
Source listing expiry
20261231

Source-listed ingredients

  • NAPROXEN SODIUM — 220 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE, PLASTIC in 1 CARTON (21130-948-11) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 21130-948-11
  • 1 BOTTLE, PLASTIC in 1 CARTON (21130-948-15) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 21130-948-15
  • 1 BOTTLE, PLASTIC in 1 CARTON (21130-948-16) / 50 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 21130-948-16
  • 80 CAPSULE, LIQUID FILLED in 1 BOTTLE (21130-948-78) · 21130-948-78

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →